The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 5,269 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 455 | 7,200 | SH | SOLE | 7,200 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 10,574 | 1,660,000 | SH | SOLE | 1,660,000 | 0 | 0 | ||
| BIND THERAPEUTICS INC | COM | 05548N107 | 6,485 | 492,000 | SH | SOLE | 492,000 | 0 | 0 | ||
| BIOLINERX LTD | COM | 09071M106 | 1,352 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| CATALYST PHARM PARTNERS INC | COM | 14888U101 | 3,488 | 1,378,584 | SH | SOLE | 1,378,584 | 0 | 0 | ||
| CELATOR PHARMACEUTICALS INC | COM | 15089R102 | 1,073 | 338,402 | SH | SOLE | 338,402 | 0 | 0 | ||
| CELGENE CORP | RIGHT 12/31/2030 | 151020112 | 1,716 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 5,417 | 504,800 | SH | SOLE | 504,800 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 17,333 | 790,000 | SH | SOLE | 790,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 5,369 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 4,207 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 1,197 | 820,000 | SH | SOLE | 820,000 | 0 | 0 | ||
| EVOKE PHARMA INC | COM | 30049G104 | 1,962 | 242,500 | SH | SOLE | 242,500 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 6,765 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| INSPIREMD INC | COM NEW | 45779A309 | 6,431 | 2,180,000 | SH | SOLE | 2,180,000 | 0 | 0 | ||
| INSYS THERAPEUTICS INC NEW | COM NEW | 45824V209 | 2,680 | 85,800 | SH | SOLE | 85,800 | 0 | 0 | ||
| KALOBIOS PHARMACEUTICALS INC | COM | 48344T100 | 730 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,397 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| KIPS BAY MED INC | COM | 49726K105 | 355 | 772,031 | SH | SOLE | 772,031 | 0 | 0 | ||
| MAZOR ROBOTICS LTD | COM | 57886P103 | 2,108 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| PHARMACYCLICS INC | COM | 716933106 | 8,971 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| PROTHENA CORP PLC | COM | G72800108 | 295 | 13,104 | SH | SOLE | 13,104 | 0 | 0 | ||
| RECRO PHARMA INC | COM | 75629F109 | 1,762 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 14,281 | 1,216,400 | SH | SOLE | 1,216,400 | 0 | 0 | ||
| TETRAPHASE PHARMACEUTICALS I | COM | 88165N105 | 2,289 | 169,700 | SH | SOLE | 169,700 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 2,020 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||